Shu Lei, Yang Zhi-Wei, Cao Ren-Xu, Qiu Xiao-Xia, Ni Feng, Shi Xiao-Xin
Engineering Research Center of Pharmaceutical Process Chemistry of the Ministry of Education, School of Pharmacy, East China University of Science and Technology 130 Mei-Long Road Shanghai 200237 P. R. China
Shanghai Shyndec Pharmaceutical Co., Ltd. 378 Jian-Lu Road Shanghai 201203 P. R. China
RSC Adv. 2023 Sep 4;13(37):26160-26168. doi: 10.1039/d3ra04721k. eCollection 2023 Aug 29.
Bicyclic hydantoinothiolactone (1), as the key intermediate for production of (+)-biotin, has been efficiently and high-stereoselectively synthesized from the cheap starting material l-cystine nine steps in 44% overall yield. In this new practical synthesis, there are two characteristic steps worthy of note. One step is TMSOTf-catalyzed efficient cyanation of (3,7a)-6-benzyl-5-oxo-3-phenyltetrahydro-1,3-imidazo[1,5-]thiazol-7-yl acetate, the other step is DBU-catalyzed rapid isomerization of -isomer to -isomer of the bicyclic hydantoinothiolactone.
双环乙内酰脲硫代内酯(1)作为生产(+)-生物素的关键中间体,已从廉价起始原料L-胱氨酸出发,经九步反应以44%的总收率高效且高立体选择性地合成出来。在这种新的实用合成方法中,有两个值得注意的特征步骤。一步是三甲基甲磺酸钪催化(3,7a)-6-苄基-5-氧代-3-苯基四氢-1,3-咪唑并[1,5-a]噻唑-7-基乙酸酯的高效氰化反应,另一步是1,8-二氮杂双环[5.4.0]十一碳-7-烯催化双环乙内酰脲硫代内酯的α-异构体快速异构化为β-异构体反应。